HOYA CORPORATION

HOYA CORPORATION

156.48
USD
+0.23
(+0.15%)
4.84EPS
33.16P/E
53.82BMarket Cap
Feb 02Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,009.38
1,168.03
1,249.01
1,255.48
1,408.59
1,510.2
1,547.06
1,497.2
1,822.71
2,048.91
2,257.08
2,548.49
2,932.96
- -
Basic EPS, GAAP
135.53
218.66
225.89
222.37
258.97
322.18
303.87
336.43
447.32
470.68
516.49
581.45
745.38
- -
Free Cash Flow per Basic Share
199.9
228.54
275.67
220.81
305.9
316.41
313.91
323.34
438.28
469.89
517.49
538.55
653.44
- -
Dividend per Share
65.22
75.64
76.36
75.49
75.59
90.08
90.42
90.43
90.28
111.07
110.42
110.53
241.22
296.29
Book Value per Share
1,244.12
1,394.49
1,246.12
1,318.98
1,389.2
1,643.23
1,723.48
1,866.6
2,205.99
2,316.24
2,766.31
2,847.28
3,047.66
- -
Tangible Book Value per Share
1,163.17
1,324.46
1,180.89
1,213.12
1,207.68
1,413.42
1,504.71
1,669.09
1,999.02
2,082.58
2,518.24
2,622.75
2,820.73
- -
Basic Weighted Avg Shares
431
424
412
390
384
379
377
373
368
358
351
348
340
336
Sales/Revenue/Turnover
434,877
495,733
515,185
489,729
541,173
572,358
582,470
558,264
670,325
734,095
792,628
885,815
995,844
- -
Operating Margin (%)
43.82
47.53
49.4
51.11
52.14
54.45
52.04
54.55
54.22
54.61
54.69
54.28
55.34
- -
Depreciation Expense
33,891
34,852
33,524
29,777
28,711
26,416
34,374
36,336
43,019
49,615
47,215
48,577
58,218
- -
Net Income, GAAP
58,390
92,804
93,175
86,740
99,494
122,103
114,406
125,446
164,507
168,638
181,376
202,102
253,084
- -
Effective Tax Rate (%)
29.65
21.4
21.65
21.61
20.14
15.61
22.19
21.35
21.54
21.8
22.83
22.39
23.26
- -
Profit Margin (%)
13.43
18.72
18.09
17.71
18.38
21.33
19.64
22.47
24.54
22.97
22.88
22.82
25.41
- -
Working Capital
397,835
459,699
378,507
364,581
341,913
396,341
388,778
422,974
535,585
554,056
687,663
700,223
761,078
- -
LT Debt
35,829
35,528
35,404
504
451
904
14,472
13,234
13,763
15,997
20,590
28,007
31,517
- -
Total Equity
542,648
596,095
498,174
515,405
530,677
627,707
629,265
672,412
789,056
814,604
962,264
971,629
1,035,004
- -
Return on Invested Capital (%)
22.57
29.27
33.3
35.21
39.77
44.23
36.01
33.8
36.83
36.9
34.94
35.9
38.87
- -
Return on Capital (%)
10.11
15.1
16.05
16.08
18.49
21.05
17.92
18.93
21.94
20.6
19.85
20.35
24.57
- -
Return on Common Equity (%)
11.59
16.48
17.2
17.28
19.19
21.25
18.04
18.82
22.05
20.79
20.31
20.82
25.38
- -

Capital Structure

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
ST Debt
10,724
11,379
- -
LT Borrowings
31,517
34,012
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
335
334
333
Market Capitalization
9,168,590
8,749,210
7,836,242

Working Capital

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
Total Current Assets
960,752
951,239
- -
Cash, Cash Equivalents & STI
578,843
559,148
- -
Accounts Receivable, Net
209,613
212,231
- -
Inventories
132,482
136,519
- -
Total Current Liabilities
199,674
193,802
- -
Payables & Accruals
- -
- -
- -
ST Debt
10,724
11,379
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.8%
9.24%
6.52%
Free Cash Flow
8.24%
13.52%
18.52%
Net Income, GAAP
11.17%
15.57%
25.23%
Sales/Revenue/Turnover
7.07%
12.35%
12.42%
Total Cash Common Dividend
13.65%
25.61%
113.19%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
218,918
219,104
225,621
222,172
885,815
2026
221,001
238,587
279,858
252,837
995,844
2027
257,012
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
137.85
152.31
145.35
149.53
581.45
2026
151.54
161.95
270.54
161.06
745.38
2027
197
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
66.38
0.16
45.03
0.04
110.53
2026
114.96
0.18
125.5
0.08
241.22
2027
170.41
- -
- -
- -
- -

Company Description

CEO
Eiichiro Ikeda
Full Time Employees
37,752
Sector
Health technology
Industry
Medical specialties
Address
Nittochi Nishishinjuku Building Tokyo TY Japan 160-8347
IPO Date
Oct 2, 1961
Website
hoya.co.jp
Business
HOYA Corporation is a Japanese multinational company founded in 1941 and headquartered in Tokyo, Japan, specializing in healthcare and information technology products. The company manufactures and sells a wide range of optical and medical products, including eyeglasses, contact lenses, intraocular lenses, medical endoscopes, and lens care solutions under its Life Care segment. In its Information Technology segment, HOYA produces high-precision photomasks essential for semiconductor manufacturing, optical lenses for electronic devices, coated filters, and special glass used in electronics, LCD panels, and hard disk drives. HOYA operates globally with manufacturing and sales facilities across Asia, Europe, the Americas, and other regions. Recent major developments include HOYA Vision Care's acquisition of Centennial Optical, a Canadian distributor of ophthalmic frames, eyeglass lenses, sunglasses, and optical accessories, strengthening its market presence in Canada and expanding its distribution capabilities. HOYA also completed the acquisition of the remaining shares of PLASMABIOTICS SAS, enhancing its medical technology portfolio, and acquired the safety prescription eyewear business from 3M, further diversifying its eyewear offerings. The company maintains a strategic focus on innovation in myopia management and advanced lens technology, launching new features and courses through the HOYA Learning Center. In fiscal 2025, the company reported sustained strong sales growth with expanding margins in its life care segment and robust demand for semiconductor-related products. HOYA targets professional eyecare providers, semiconductor manufacturers, and advanced technology sectors with its comprehensive product portfolio. The company's Life Care business addresses broad eye health needs worldwide, while its Information Technology segment supports technological miniaturization and digital innovation. Recent strategic moves and technology investments underscore HOYA’s commitment to growing its global footprint and enhancing its competitive position in healthcare and high-tech industries.

Company News

  • APELY vs. HOCPY: Which Stock Is the Better Value Option?

  • Hoya (OTCMKTS:HOCPY) Shares Gap Up – Should You Buy?

  • Hoya (OTCMKTS:HOCPY) Shares Cross Above 50-Day Moving Average – Time to Sell?

  • Head to Head Analysis: Hoya (OTCMKTS:HOCPY) and Richardson Electronics (NASDAQ:RELL)

  • MKSI or HOCPY: Which Is the Better Value Stock Right Now?

  • HAYW or HOCPY: Which Is the Better Value Stock Right Now?

  • Hoya (HOCPY) Projected to Post Quarterly Earnings on Friday

  • DKILY vs. HOCPY: Which Stock Is the Better Value Option?

  • TKR or HOCPY: Which Is the Better Value Stock Right Now?

  • Expion360 (NASDAQ:XPON) & Hoya (OTCMKTS:HOCPY) Head-To-Head Review

  • HAYW vs. HOCPY: Which Stock Is the Better Value Option?

  • Are Computer and Technology Stocks Lagging Hoya (HOCPY) This Year?

  • Hoya (OTCMKTS:HOCPY) Shares Gap Up – Here’s Why

  • Hoya (OTCMKTS:HOCPY) Shares Gap Down – Here’s What Happened

  • Hoya Corp. (OTCMKTS:HOCPY) Sees Significant Growth in Short Interest

  • KE or HOCPY: Which Is the Better Value Stock Right Now?

  • Analyzing Brother Industries (OTCMKTS:BRTHY) and Hoya (OTCMKTS:HOCPY)

  • KE vs. HOCPY: Which Stock Is the Better Value Option?

  • SiTime (NASDAQ:SITM) vs. Hoya (OTCMKTS:HOCPY) Financial Review

  • SNX vs. HOCPY: Which Stock Should Value Investors Buy Now?